Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • Manuscripts submitted for publication in Lebda Medical Journal can be in Arabic or in English. 

  • Manuscripts can be review articles, original articles, short communications or case reports. Letter to editor could it’s also accepted. 

  • The manuscript should be carefully prepared, double-spaced and pages numbered. 

  • Original articles generally should not exceed 4000 words.

  • Manuscripts must be submitted electronically through our website.

  • Submitted manuscripts should be accompanied by letter from the corresponding author(s) indicating that no part of the submitted work has previously been published (in print or electronic format) or is not under simultaneous consideration by another publication or electronic medium. Under no circumstances will any manuscript be considered for publication in LebMed.J that contains any data that have been published or submitted for publication elsewhere.

  • Manuscripts reporting studies involving human subjects must be accompanied by a statement from the main author confirming that informed consent was obtained from all subjects involved. This statement must also appear in the Materials and methods section of the manuscript.

  • Manuscripts reporting studies involving live animals (vertebrates) must be accompanied by a statement from the main author confirming that experiments were performed in accordance with relevant national guidelines and regulations.

  • he contents of the manuscript should be arranged under the following headings: Abstract, Introduction, Materials and methods, Results, Discussion, Conclusion, Acknowledgements, References, Figure and Table Legends, The first page should comprise: Title of the paper, name(s) of the author(s), Affiliations, the exact contact information of the author must be given in detail at the end of the manuscript

    • Title: Should occupy no more than three lines. Title should clearly convey the conceptual significance of the paper to a broad readership.
    • Authors/Affiliations: Author name(s) should be written as first name, followed by initials of middle name and then last name: as Ahmed M. Tolmami. If two authors are involved, they should be written as Ahmed M. Tolmani and Mohamed I. Salem. If more than two authors are involved, then they should be written as Ahmed M. Tolmani, Mohamed I. Salem and Kadhem S. Rajab. Affiliations should contain the following core information: department(s), institution(s), city, country.
    • Contact Information: Contact line should include the e-mail address and/or phone/fax numbers of the corresponding author.
    • Abstract: Abstract should be composed of a single paragraph of no more than 300 words. It should contain a brief background of the question, a description of the results without extensive experimental details and a summary of the significance of the findings.
    • Introduction: The introduction should be concise, with no subheadings and should present the background information necessary to provide a logical context for the results.
    • Materials and methods: This section needs to include sufficient details so that readers can understand how the experiments were carried out. This section should also include a description of the statistical methods employed in the study.
    • Results: This section should be divided into subheadings, so the reader can follow the logic of results development.
    • Discussion: The discussion should explain the significance of the results and place them into a broader context. It should not be redundant with the results section.
    • References: References listed as numbered in this form [1]., [2]., [3]., etc, and should include only articles that are published or in press.
    • Journal name, volume and page numbers and overall reference style should be as follows: A. J. Browne, C. M. Varcoe, S. T. Wong, V. L. Smye, J. Lavoie, D. Littlejohn, D. Tu, O. Godwin, M. Krause, K. B. Khan, A. Fridkin, P. Rodney, J. O. Neil, and S. Lennox, Closing the health equity gap: Evidence-based strategies for primary health care organizations. International Journal for Equity in Health, 2012. 11(1): p. 59-73Unpublished observations and “personal communications” may not be used as references but may be inserted in parentheses in the text.
    • Reference list format is as follows: References are listed in order indicating family name followed by initials of first author.
    • Citations ‘In press’ must have been accepted for publication and the name of the journal or publisher included.
    • Initials should follow all surnames in the list of authors; insert a full stop and space after each initial and bold date without parentheses.
    • Complete title of the article should be included in curved form followed by full stop. 
  • Use system international (SI) measurements throughout the manuscript.

  • Use generic names of drugs, unless the trade name is directly relevant to the discussion.

  • Acknowledge all illustrations and tables or long annotation taken from other publications and submit written permission to reprint from the original publishers.

  • Abbreviations in the title or abstract section are not allowed.

  • All submissions are initially evaluated by the editorial board. Papers that do not conform to the general format mentioned above will be returned to the authors for reformatting.

  • Papers not accepted before refereed are returned within four weeks of acknowledgment of receipt.

  • Encouraging papers are refereed by two referees in addition to a statistical referee if needed and if not accepted are returned within 50 working days.

  • Papers accepted are sent back for revision on the bases of comments received. Authors should give such revision priority and reciprocate with the journal to take a final decision by sending back by email the revised version and one of them should annotate to show where changes have been made. Also, provide a covering letter indicating detailed responses to reviewer’s comments.

  • Authors are advised to keep raw data stored up to five years because at any time after publication of a research paper you may be asked to submit these data to the journal.

  • Cover letter statement for transfer of copyright ownership: “In consideration of the LebMed.J taking action in reviewing and editing this submission, the author(s) undersigned hereby transfer(s) all copyright ownership to LebMed.J in case this work is published by LebMed.J.”

  • Signature of the main author is to be submitted with the manuscript: “I declare that I contributed with my colleagues entitled in the design, execution and analysis of the paper and I have approved the final version. I here also declare that I have no conflict of interest in connection with this paper, other than any noted in the covering letter to the editor”

Author Guidelines

Articles submitted to LebMedJ should meet the following requirements:

Privacy Statement

The names and email addresses entered in Lebmedj site will be used exclusively for the stated purposes of the journal and will not be made available for any other purpose or to any other party.